Shares of TransMedics Group (NASDAQ: TMDX) were tanking 14.3% lower as of 10:46 a.m. ET on Friday. The big sell-off came ...

Shares of Transmedics (NASDAQ: TMDX) fell 28.1% in December, according to data from S&P Global Market Intelligence. On Dec. 2 ...

TransMedics is a commercial-stage medical technology company working on organ transplant therapy. Check out more about the ...

The report further alleges that TransMedics has been involved in kickbacks, billing fraud, unreported device failures, and ...

In this video, I will talk about TransMedics (NASDAQ: TMDX) and the recent short-seller report. Watch the short video to learn more, consider subscribing, and click the special offer link below.

Discover how TransMedics is revolutionizing organ transplants with cutting-edge technology and logistics, offering a ...

EST TransMedics (TMDX) down 10% to $65.39 after Scorpion Capital short reportStay Ahead of the Market:Discover outperforming stocks and ...

In diabetes care, the MiniMed 780G insulin pump system uses AI algorithms to predict and adjust insulin delivery based on ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

As substantial as TransMedics' stock sell-off has been, its underlying business is by no means 63% worse. As we keep our gaze ...

Philadelphia, Pennsylvania-- (Newsfile Corp. - January 10, 2025) - Kehoe Law Firm, P.C. is investigating potential securities class action claims on behalf of investors of TransMedics Group, Inc.

TransMedics Group Inc (TMDX) stock saw a decline, ending the day at $72.55 which represents a decrease of $-6.12 or -7.78% from the prior close of $78.67. The stock opened at $75.81 and touched a low ...